Literature DB >> 17764997

Analysis of CYP2D6 substrate interactions by computational methods.

Yuko Ito1, Hiroki Kondo, Peter S Goldfarb, David F V Lewis.   

Abstract

Cytochrome P450 CYP2D6 is involved in the oxidation of well over 150 drugs and, in general, those which contain a basic nitrogen atom in the molecule. To clarify how the residues of CYP2D6 are utilized for orientating a wide range of its specific substrates and distinguishing them from a variety of other organic compounds, docking studies by AutoDock and molecular dynamics (MD) simulations were conducted. Specific ligands were docked to both the homology model and crystal structures optimally to estimate the site of reaction on the ligand molecule and the binding energy for the complex, which were generally in good agreement with the experimental data. MD simulation for the CYP2D6-propranolol complex was then carried out to reveal the amino acid residues interacting with the substrate at the active site. Phe-120, Glu-216, Asp-301, and Phe-483 are identified as the substrate-binding residues in agreement with previously reported site-directed mutagenesis data and the crystal structure reported recently (PDB code: 2F9Q). As well as these residues, our theoretical prediction suggests that Phe-219 and Glu-222 are also important residues for mediating oxidation of substrates, especially propranolol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764997     DOI: 10.1016/j.jmgm.2007.07.004

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  7 in total

1.  Theoretical studies on the interaction of biphenyl inhibitors with Mycobacterium tuberculosis protein tyrosine phosphatase MptpB.

Authors:  Lihua Dong; Junyou Shi; Yongjun Liu
Journal:  J Mol Model       Date:  2012-03-11       Impact factor: 1.810

2.  Molecular analysis and modeling of inactivation of human CYP2D6 by four mechanism based inactivators.

Authors:  Mara Livezey; Leslie D Nagy; Laura E Diffenderfer; Evan J Arthur; David J Hsi; Jeffrey M Holton; Laura Lowe Furge
Journal:  Drug Metab Lett       Date:  2012-03

3.  Substituted imidazole of 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine Inactivates cytochrome P450 2D6 by protein adduction.

Authors:  Leslie D Nagy; Catherine S Mocny; Laura E Diffenderfer; David J Hsi; Brendan F Butler; Evan J Arthur; Kyle J Fletke; Jairam R Palamanda; Amin A Nomeir; Laura Lowe Furge
Journal:  Drug Metab Dispos       Date:  2011-03-21       Impact factor: 3.922

4.  A computational study of CYP3A4 mediated drug interaction profiles for anti-HIV drugs.

Authors:  Jayakanthan Mannu; Pranitha Jenardhanan; Premendu P Mathur
Journal:  J Mol Model       Date:  2010-11-16       Impact factor: 1.810

5.  Microsecond MD simulations of human CYP2D6 wild-type and five allelic variants reveal mechanistic insights on the function.

Authors:  Charleen G Don; Martin Smieško
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

6.  Rationalization of stereospecific binding of propranolol to cytochrome P450 2D6 by free energy calculations.

Authors:  Gabor Nagy; Chris Oostenbrink
Journal:  Eur Biophys J       Date:  2012-10-20       Impact factor: 1.733

7.  Molecular Dynamics Simulations to Investigate the Influences of Amino Acid Mutations on Protein Three-Dimensional Structures of Cytochrome P450 2D6.1, 2, 10, 14A, 51, and 62.

Authors:  Shuichi Fukuyoshi; Masaharu Kometani; Yurie Watanabe; Masahiro Hiratsuka; Noriyuki Yamaotsu; Shuichi Hirono; Noriyoshi Manabe; Ohgi Takahashi; Akifumi Oda
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.